Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 Catherine Saez The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading -> FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
FIND Announces Four New Collaborations To Address AMR 31/01/2018 Catherine Saez The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading -> Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 Catherine Saez An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading -> Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 Catherine Saez The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading -> Posts navigation Older postsNewer posts